Publications by authors named "Peter G Milner"

Claim this Profile
A
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitor.
Megan Yerton, Allison Winter, Anthony Kostov, Cassandra Lieberman, Dario Gelevski, Peter G Milner

Muscle Nerve· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease.
Detlef Albrecht, Mintu P Turakhia, Daniel Ries, Thomas Marbury, William Smith, Peter G Milner

Thromb Haemost· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.
Detlef Albrecht, David Ellis, Daniel M Canafax, Daniel Combs, Pascal Druzgala, Peter G Milner

Thromb Haemost· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin. The EmbraceAC Trial.
Richard P Whitlock, Christopher B Fordyce, Mark G Midei, Dave Ellis, David Garcia, Peter G Milner

Thromb Haemost· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of budiodarone in paroxysmal atrial fibrillation.
Michael D Ezekowitz, Rangadham Nagarakanti, Andrzej Lubinski, Olga Bandman, Daniel Canafax, Peter G Milner

J Interv Card Electrophysiol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participants.
Linda M Bavisotto, David J Ellis, Peter G Milner, Daniel L Combs, Ian Irwin

J Clin Pharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation.
David J Ellis, Mohammed Haris Usman, Peter G Milner, Daniel M Canafax, Michael D Ezekowitz

Circulation· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis